SYNCROSOME provides relevant disease models (in cardiology, CNS , gastroenterology, metabolic disorders and respiratory fields), cutting-edge techniques, specific biomarkers and comprehensive background of physiopathology to assist drug discovery companies in selecting their compounds.
SYNCROSOME has developed and validated so far more than 20 disease models, and our flexible and human sized organization can design and operate tailored in vivo experimental